{"data":{"id":"us-in/ic-16-41-12-2.5","jurisdiction":"us-in","citation":"IC 16-41-12-2.5","heading":"Blood","body":"Sec. 2.5. (a) As used in this chapter, \"blood\" means any of the following:\n(1) Human blood.\n(2) Human blood components.\n(3) Human blood derivatives.\n(b) The term does not include human cells, tissues, or cellular or tissue-based products (HCT/Ps).","path":["TITLE 16. HEALTH","ARTICLE 41. PUBLIC HEALTH MEASURES FOR THE PREVENTION AND CONTROL OF DISEASE","Chapter 12. Communicable Disease: Precautionary Measures for Use of Human Tissues and Blood Products; Regulation of Blood Centers"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-41-12-2.5","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"a6214ab170c3f190153f8842514194781e55f46e2242e6373e64d39eb85b7917","source_id":"us-in","stale":false,"prev":"us-in/ic-16-41-12-2","next":"us-in/ic-16-41-12-3"},"notice":"GroundRules: Original legal text. Not legal advice."}